SCIENTIFIC PROGRAMME
SESSION I
HOW I TREAT
SMOLDERING MYELOMA
(SMM)
SESSION II
HOW I TREAT NEWLY
DIAGNOSED MULTIPLE
MYELOMA
SESSION III
FROM RISK
STRATIFICATION TO
RISK-BASED THERAPY?
DEBATE 1
SHOULD WE USE MRD
TESTING TO DETERMINE
THERAPY IN MULTIPLE
MYELOMA?
DEBATE 2
IS THERE A FUTURE ROLE
OF AUTOLOGOUS STEM
CELL TRANSPLANTATION?
SESSION IV
HOW I TREAT RELAPSED
MULTIPLE MYELOMA
DEBATE 3
SHOULD EVERY PATIENT
RECEIVE DARATUMUMAB
IN FIRST LINE?
ROUNDTABLE
MULTIPLE MYELOMA
FROM THE PERSPECTIVE
OF FDA/EMEA AND
FOUNDATIONS
SESSION V
YOU CAN’T BE IMMUNE
FOR IMMUNE THERAPY
ANYMORE
SESSION VI
OTHER PLASMA CELL
DYSCRASIAS
KEYNOTE LECTURES
THE FUTURE OF
MULTIPLE MYELOMA
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
ABSTRACTS SELECTED
AS POSTERS
DISCLOSURES
3rd How to Diagnose and Treat
MULTIPLE MYELOMA
April 15-18, 2021
DISCLOSURES
K. C. ANDERSON Pfizer Consultant
Janssen Consultant
Amgen Consultant
Arch Scientific Advisory Board
Precision Biosciences Scientific Advisory Board
Mona Scientific Advisory Board
CytoTherapeutics Founder
Oncopeptides Founder
D. AUCLAIR No affiliation
J. BLADE Janssen Scientific Advisory Board, Honoraria for lectures
Celgene Honoraria for lectures
Amgen Honoraria for lectures
Oncopeptides Scientific Advisory Board, Honoraria for lectures
Samir Parekh.jpg
F. DAVIES Adaptive Biotech Parekh Biosketch 01.19.21.doc
Celgene / BMS Research Support, Scientific Advisory Board
Janssen Research Support, Consultant, Scientific Advisory Board
Roche Scientific Advisory Board
M. DHODAPKAR BMS Scientific Advisory Board
Amgen Scientific Advisory Board
Janssen Scientific Advisory Board
Genentech / Roche Scientific Advisory Board
Lava Rx Scientific Advisory Board
A. DISPENZIERI Takeda Research Support
Pfizer Research Support
Prothena Research Support
Celgene Research Support
Alnylam Research Support, Scientific Advisory Board
Janssen Research Support, Scientific Advisory Board
Intellia Scientific Advisory Board
H. EINSELE Janssen Research Support, Consultant, Speakers' Bureau, Scientific Advisory Board
BMS / Celgene Research Support, Consultant, Speakers' Bureau, Scientific Advisory Board
Amgen Research Support, Consultant, Speakers' Bureau, Scientific Advisory Board
Novartis Research Support, Consultant, Speakers' Bureau, Scientific Advisory Board
Takeda Consultant, Speakers' Bureau, Scientific Advisory Board
Sanofi Research Support, Speakers' Bureau, Scientific Advisory Board
GSK Research Support, Speakers' Bureau, Scientific Advisory Board
F. GAY Janssen Consultant, Scientific Advisory Board, Honoraria
Roche Consultant, Scientific Advisory Board, Honoraria
Abbvie Consultant, Scientific Advisory Board, Honoraria
Amgen Consultant, Scientific Advisory Board, Honoraria
Sanofi Consultant, Scientific Advisory Board, Honoraria
BMS Consultant, Scientific Advisory Board, Honoraria
Takeda Consultant, Scientific Advisory Board, Honoraria
Oncopeptides Scientific Advisory Board
Adaptive Biotech Scientific Advisory Board
I. GHOBRIAL GSK Consultant, Scientific Advisory Board
Sanofi Consultant
Janssen Consultant
Takeda Consultant
Karyopharm Consultant
AbbVie Consultant
GNS Consultant, Scientific Advisory Board
Cellectar Consultant
Medscape Consultant
Genentech Consultant
Adaptive Biotech Consultant
BMS Consultant
Aptitude Consultant, Scientific Advisory Board
Curio Science Consultant
Oncopeptides Consultant
J.L. HAROUSSEAU Janssen Speakers' Bureau
GSK Consultant
Novartis Speakers' Bureau
B. KANAPURU No affiliation
S. KNOP BMS Research Support, Consultant, Scientific Advisory Board
Janssen Consultant, Scientific Advisory Board
Amgen Consultant
Molecular Partners Consultant, Scientific Advisory Board
O. LANDGREN Celgene Research Support, Scientific Advisory Board
Janssen Research Support, Scientific Advisory Board, IDMC